Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum for: Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease.
Rieder F, Baker ME, Bruining DH, Fidler JL, Ehman EC, Sheedy SP, Heiken JP, Ream JM, Holmes DR 3rd, Inoue A, Mohammadinejad P, Lee YS, Taylor SA, Stoker J, Zou G, Wang Z, Rémillard J, Carter RE, Ottichilo R, Atkinson N, Siddiqui MT, Sunkesula VC, Ma C, Parker CE, Panés J, Rimola J, Jairath V, Feagan BG, Fletcher JG; Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium. Rieder F, et al. Among authors: ottichilo r. Radiology. 2024 Oct;313(1):e249020. doi: 10.1148/radiol.249020. Radiology. 2024. PMID: 39470432 Free PMC article. No abstract available.
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease.
Rieder F, Ma C, Hanzel J, Fletcher JG, Baker ME, Wang Z, Guizzetti L, Shackelton LM, Rémillard J, Patel M, Niu J, Ottichilo R, Santillan CS, Capozzi N, Taylor SA, Bruining DH, Zou G, Feagan BG, Jairath V, Rimola J; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Rieder F, et al. Among authors: ottichilo r. Radiology. 2024 Aug;312(2):e233038. doi: 10.1148/radiol.233038. Radiology. 2024. PMID: 39105638
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease.
Rieder F, Baker ME, Bruining DH, Fidler JL, Ehman EC, Sheedy SP, Heiken JP, Ream JM, Holmes DR 3rd, Inoue A, Mohammadinejad P, Lee YS, Taylor SA, Stoker J, Zou G, Wang Z, Rémillard J, Carter RE, Ottichilo R, Atkinson N, Siddiqui MT, Sunkesula VC, Ma C, Parker CE, Panés J, Rimola J, Jairath V, Feagan BG, Fletcher JG; Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium. Rieder F, et al. Among authors: ottichilo r. Radiology. 2024 Aug;312(2):e233039. doi: 10.1148/radiol.233039. Radiology. 2024. PMID: 39105637
Biomarkers for the Evaluation of Pouch Inflammation: A Systematic Review.
Falloon K, Cohen BL, Ottichilo R, Grove D, Rieder F, Qazi T. Falloon K, et al. Among authors: ottichilo r. Crohns Colitis 360. 2022 Nov 24;4(4):otac043. doi: 10.1093/crocol/otac043. eCollection 2022 Oct. Crohns Colitis 360. 2022. PMID: 36778511 Free PMC article.
The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Juma DW, Muiruri P, Yuhas K, John-Stewart G, Ottichilo R, Waitumbi J, Singa B, Polyak C, Kamau E. Juma DW, et al. Among authors: ottichilo r. PLoS Negl Trop Dis. 2019 Mar 21;13(3):e0007223. doi: 10.1371/journal.pntd.0007223. eCollection 2019 Mar. PLoS Negl Trop Dis. 2019. PMID: 30897090 Free PMC article. Clinical Trial.